{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:55:40Z","timestamp":1792605340155,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T00:00:00Z","timestamp":1678147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T00:00:00Z","timestamp":1678147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s10557-023-07441-4","type":"journal-article","created":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T03:02:49Z","timestamp":1678158169000},"page":"705-718","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Levosimendan Reverses Cardiac Malfunction and Cardiomyocyte Ferroptosis During Heart Failure with Preserved Ejection Fraction via Connexin 43 Signaling Activation"],"prefix":"10.1007","volume":"38","author":[{"given":"Li-li","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui-hao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-jie","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-yan","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-yang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao-ting","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-song","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1800-4566","authenticated-orcid":false,"given":"Yue-jin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,7]]},"reference":[{"issue":"4","key":"7441_CR1","doi-asserted-by":"publisher","first-page":"531","DOI":"10.31083\/j.rcm.2020.04.154","volume":"21","author":"N Nair","year":"2020","unstructured":"Nair N. Epidemiology and pathogenesis of heart failure with preserved ejection fraction. Rev Cardiovasc Med. 2020;21(4):531\u201340.","journal-title":"Rev Cardiovasc Med"},{"issue":"4","key":"7441_CR2","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.jchf.2018.11.019","volume":"7","author":"G Savarese","year":"2019","unstructured":"Savarese G, Vedin O, D'Amario D, et al. Prevalence and prognostic implications of longitudinal ejection fraction change in heart failure. JACC Heart Fail. 2019;7(4):306\u201317.","journal-title":"JACC Heart Fail"},{"issue":"4","key":"7441_CR3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00395-020-0798-y","volume":"115","author":"I Cuijpers","year":"2020","unstructured":"Cuijpers I, Simmonds SJ, van Bilsen M, et al. Microvascular and lymphatic dysfunction in HFpEF and its associated comorbidities. Basic Res Cardiol. 2020;115(4):39.","journal-title":"Basic Res Cardiol"},{"key":"7441_CR4","doi-asserted-by":"publisher","first-page":"928934","DOI":"10.3389\/fphys.2022.928934","volume":"13","author":"K Boengler","year":"2022","unstructured":"Boengler K, Leybaert L, Ruiz-Meana M, Schulz R. Connexin 43 in mitochondria: what do we really know about its function? Front Physiol. 2022;13:928934.","journal-title":"Front Physiol"},{"issue":"2","key":"7441_CR5","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1017\/S1431927620000033","volume":"26","author":"KT Shin","year":"2020","unstructured":"Shin KT, Nie ZW, Zhou W, et al. Connexin 43 knockdown induces mitochondrial dysfunction and affects early developmental competence in porcine embryos. Microsc Microanal. 2020;26(2):287\u201396.","journal-title":"Microsc Microanal"},{"issue":"6","key":"7441_CR6","doi-asserted-by":"publisher","first-page":"e0198619","DOI":"10.1371\/journal.pone.0198619","volume":"13","author":"DG Yi","year":"2018","unstructured":"Yi DG, Hong S, Huh WK. Mitochondrial dysfunction reduces yeast replicative lifespan by elevating RAS-dependent ROS production by the ER-localized NADPH oxidase Yno1. PLoS One. 2018;13(6):e0198619.","journal-title":"PLoS One"},{"issue":"6","key":"7441_CR7","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/s41569-020-00480-6","volume":"18","author":"S Mishra","year":"2021","unstructured":"Mishra S, Kass DA. Cellular and molecular pathobiology of heart failure with preserved ejection fraction. Nat Rev Cardiol. 2021;18(6):400\u201323.","journal-title":"Nat Rev Cardiol"},{"issue":"9","key":"7441_CR8","doi-asserted-by":"publisher","first-page":"860","DOI":"10.3390\/antiox9090860","volume":"9","author":"D Bode","year":"2020","unstructured":"Bode D, Wen Y, Hegemann N, et al. Oxidative stress and inflammatory modulation of Ca(2+) handling in metabolic HFpEF-related left atrial cardiomyopathy. Antioxidants (Basel). 2020;9(9):860.","journal-title":"Antioxidants (Basel)."},{"key":"7441_CR9","doi-asserted-by":"publisher","first-page":"8810785","DOI":"10.1155\/2020\/8810785","volume":"2020","author":"J Zhu","year":"2020","unstructured":"Zhu J, Xiong Y, Zhang Y, et al. The molecular mechanisms of regulating oxidative stress-induced ferroptosis and therapeutic strategy in tumors. Oxidative Med Cell Longev. 2020;2020:8810785.","journal-title":"Oxidative Med Cell Longev"},{"issue":"19","key":"7441_CR10","doi-asserted-by":"publisher","first-page":"4968","DOI":"10.3390\/ijms20194968","volume":"20","author":"N Kajarabille","year":"2019","unstructured":"Kajarabille N, Latunde-Dada GO. Programmed cell-death by ferroptosis: antioxidants as mitigators. Int J Mol Sci. 2019;20(19):4968.","journal-title":"Int J Mol Sci."},{"issue":"1","key":"7441_CR11","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.bbrc.2018.02.061","volume":"497","author":"B Liu","year":"2018","unstructured":"Liu B, Zhao C, Li H, et al. Puerarin protects against heart failure induced by pressure overload through mitigation of ferroptosis. Biochem Biophys Res Commun. 2018;497(1):233\u201340.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"7441_CR12","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s00395-015-0507-4","volume":"110","author":"S Wagner","year":"2015","unstructured":"Wagner S, Sch\u00fcrmann S, Hein S, Sch\u00fcttler J, Friedrich O. Septic cardiomyopathy in rat LPS-induced endotoxemia: relative contribution of cellular diastolic Ca(2+) removal pathways, myofibrillar biomechanics properties and action of the cardiotonic drug levosimendan. Basic Res Cardiol. 2015;110(5):507.","journal-title":"Basic Res Cardiol"},{"issue":"3","key":"7441_CR13","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1093\/cvr\/cvz163","volume":"116","author":"P Efentakis","year":"2020","unstructured":"Efentakis P, Varela A, Chavdoula E, et al. Levosimendan prevents doxorubicin-induced cardiotoxicity in time- and dose-dependent manner: implications for inotropy. Cardiovasc Res. 2020;116(3):576\u201391.","journal-title":"Cardiovasc Res"},{"key":"7441_CR14","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ejphar.2018.04.006","volume":"829","author":"L Yu","year":"2018","unstructured":"Yu L, Yuan K, Park BM, Kim SH. Modification of levosimendan-induced suppression of atrial natriuretic peptide secretion in hypertrophied rat atria. Eur J Pharmacol. 2018;829:54\u201362.","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"7441_CR15","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1177\/1099800419861694","volume":"21","author":"R Rodr\u00edguez-Gonz\u00e1lez","year":"2019","unstructured":"Rodr\u00edguez-Gonz\u00e1lez R, Pollesello P, Baluja A, \u00c1lvarez J. Effects of Levosimendan on inflammation and oxidative stress pathways in a lipopolysaccharide-stimulated human endothelial cell model. Biol Res Nurs. 2019;21(5):466\u201372.","journal-title":"Biol Res Nurs"},{"issue":"7","key":"7441_CR16","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.21037\/tau-21-443","volume":"10","author":"L Zhao","year":"2021","unstructured":"Zhao L, Tian L, Wang S, et al. Levosimendan in rats decreases acute kidney injury after cardiopulmonary resuscitation by improving mitochondrial dysfunction. Transl Androl Urol. 2021;10(7):3010\u201320.","journal-title":"Transl Androl Urol"},{"issue":"5","key":"7441_CR17","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.jchf.2021.01.015","volume":"9","author":"D Burkhoff","year":"2021","unstructured":"Burkhoff D, Borlaug BA, Shah SJ, et al. Levosimendan improves hemodynamics and exercise tolerance in PH-HFpEF: results of the randomized placebo-controlled HELP trial. JACC Heart Fail. 2021;9(5):360\u201370.","journal-title":"JACC Heart Fail"},{"issue":"1","key":"7441_CR18","doi-asserted-by":"publisher","first-page":"7159","DOI":"10.1038\/s41598-017-07658-y","volume":"7","author":"S-N Kim","year":"2017","unstructured":"Kim S-N, Kwon H-J, Im S-W, et al. Connexin 43 is required for the maintenance of mitochondrial integrity in brown adipose tissue. Sci Rep. 2017;7(1):7159.","journal-title":"Sci Rep"},{"issue":"2","key":"7441_CR19","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s10741-014-9457-4","volume":"20","author":"AT Akhmedov","year":"2015","unstructured":"Akhmedov AT, Rybin V, Mar\u00edn-Garc\u00eda J. Mitochondrial oxidative metabolism and uncoupling proteins in the failing heart. Heart Fail Rev. 2015;20(2):227\u201349.","journal-title":"Heart Fail Rev"},{"issue":"4","key":"7441_CR20","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1161\/CIRCRESAHA.119.315767","volume":"126","author":"AE Dikalova","year":"2020","unstructured":"Dikalova AE, Pandey A, Xiao L, et al. Mitochondrial deacetylase Sirt3 reduces vascular dysfunction and hypertension while Sirt3 depletion in essential hypertension is linked to vascular inflammation and oxidative stress. Circ Res. 2020;126(4):439\u201352.","journal-title":"Circ Res"},{"key":"7441_CR21","doi-asserted-by":"publisher","first-page":"6643382","DOI":"10.1155\/2021\/6643382","volume":"2021","author":"JX Ren","year":"2021","unstructured":"Ren JX, Li C, Yan XL, et al. Crosstalk between oxidative stress and ferroptosis\/oxytosis in ischemic stroke: possible targets and molecular mechanisms. Oxidative Med Cell Longev. 2021;2021:6643382.","journal-title":"Oxidative Med Cell Longev"},{"issue":"7752","key":"7441_CR22","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41586-019-1100-z","volume":"568","author":"GG Schiattarella","year":"2019","unstructured":"Schiattarella GG, Altamirano F, Tong D, et al. Nitrosative stress drives heart failure with preserved ejection fraction. Nature. 2019;568(7752):351\u20136.","journal-title":"Nature"},{"issue":"47","key":"7441_CR23","doi-asserted-by":"publisher","first-page":"3859","DOI":"10.1093\/eurheartj\/ehz835","volume":"40","author":"CSP Lam","year":"2019","unstructured":"Lam CSP, Arnott C, Beale AL, et al. Sex differences in heart failure. Eur Heart J. 2019;40(47):3859\u201368c.","journal-title":"Eur Heart J"},{"issue":"11","key":"7441_CR24","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1093\/eurheartj\/ehn153","volume":"29","author":"MR MacDonald","year":"2008","unstructured":"MacDonald MR, Petrie MC, Varyani F, et al. Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: An analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme. Eur Heart J. 2008;29(11):1377\u201385.","journal-title":"Eur Heart J"},{"key":"7441_CR25","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/5584_2018_149","volume":"1067","author":"AM Ilie\u0219iu","year":"2018","unstructured":"Ilie\u0219iu AM, Hodorogea AS. Treatment of heart failure with preserved ejection fraction. Adv Exp Med Biol. 2018;1067:67\u201387.","journal-title":"Adv Exp Med Biol"},{"key":"7441_CR26","doi-asserted-by":"publisher","first-page":"9704","DOI":"10.1038\/srep09704","volume":"5","author":"M Adam","year":"2015","unstructured":"Adam M, Meyer S, Knors H, et al. Levosimendan displays anti-inflammatory effects and decreases MPO bioavailability in patients with severe heart failure. Sci Rep. 2015;5:9704.","journal-title":"Sci Rep"},{"issue":"9","key":"7441_CR27","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1161\/CIRCULATIONAHA.116.024822","volume":"135","author":"M Obokata","year":"2017","unstructured":"Obokata M, Kane GC, Reddy YN, et al. Role of diastolic stress testing in the evaluation for heart failure with preserved ejection fraction: a simultaneous invasive-echocardiographic study. Circulation. 2017;135(9):825\u201338.","journal-title":"Circulation"},{"key":"7441_CR28","doi-asserted-by":"publisher","first-page":"745328","DOI":"10.3389\/fphys.2021.745328","volume":"12","author":"RP Homme","year":"2021","unstructured":"Homme RP, Zheng Y, Smolenkova I, Singh M, Tyagi SC. Remote hind-limb ischemia mechanism of preserved ejection fraction during heart failure. Front Physiol. 2021;12:745328.","journal-title":"Front Physiol"},{"issue":"4","key":"7441_CR29","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.kint.2018.11.021","volume":"95","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, Wang C, Hong X, et al. Wnt\/\u03b2-catenin signaling mediates both heart and kidney injury in type 2 cardiorenal syndrome. Kidney Int. 2019;95(4):815\u201329.","journal-title":"Kidney Int"},{"issue":"8","key":"7441_CR30","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1177\/0271678X19880161","volume":"40","author":"DN Edwards","year":"2020","unstructured":"Edwards DN, Salmeron K, Lukins DE, et al. Integrin \u03b15\u03b21 inhibition by ATN-161 reduces neuroinflammation and is neuroprotective in ischemic stroke. J Cereb Blood Flow Metab. 2020;40(8):1695\u2013708.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"7441_CR31","doi-asserted-by":"publisher","first-page":"9628","DOI":"10.1080\/21655979.2022.2057632","volume":"13","author":"M Ji","year":"2022","unstructured":"Ji M, Cheng J, Zhang D. Oxycodone protects cardiac microvascular endothelial cells against ischemia\/reperfusion injury by binding to sigma-1 receptor. Bioengineered. 2022;13(4):9628\u201344.","journal-title":"Bioengineered"},{"issue":"1","key":"7441_CR32","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.bbamem.2017.05.018","volume":"1860","author":"I Epifantseva","year":"2018","unstructured":"Epifantseva I, Shaw RM. Intracellular trafficking pathways of Cx43 gap junction channels. Biochim Biophys Acta Biomembr. 2018;1860(1):40\u20137.","journal-title":"Biochim Biophys Acta Biomembr"},{"issue":"2","key":"7441_CR33","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.brainres.2005.02.044","volume":"1042","author":"R Kalayci","year":"2005","unstructured":"Kalayci R, Kaya M, Elmas I, et al. Effects of atorvastatin on blood-brain barrier permeability during L-NAME hypertension followed by angiotensin-II in rats. Brain Res. 2005;1042(2):184\u201393.","journal-title":"Brain Res"},{"issue":"7","key":"7441_CR34","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s12012-021-09643-4","volume":"21","author":"P Sen","year":"2021","unstructured":"Sen P, Gupta K, Kumari A, et al. Wnt\/\u03b2-Catenin antagonist pyrvinium exerts cardioprotective effects in polymicrobial sepsis model by attenuating calcium dyshomeostasis and mitochondrial dysfunction. Cardiovasc Toxicol. 2021;21(7):517\u201332.","journal-title":"Cardiovasc Toxicol"},{"key":"7441_CR35","doi-asserted-by":"publisher","first-page":"106027","DOI":"10.1016\/j.phrs.2021.106027","volume":"175","author":"C Liu","year":"2022","unstructured":"Liu C, Ma N, Guo Z, et al. Relevance of mitochondrial oxidative stress to arrhythmias: innovative concepts to target treatments. Pharmacol Res. 2022;175:106027.","journal-title":"Pharmacol Res"},{"key":"7441_CR36","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.yjmcc.2016.01.023","volume":"92","author":"S Veeranki","year":"2016","unstructured":"Veeranki S, Givvimani S, Kundu S, et al. Moderate intensity exercise prevents diabetic cardiomyopathy associated contractile dysfunction through restoration of mitochondrial function and connexin 43 levels in db\/db mice. J Mol Cell Cardiol. 2016;92:163\u201373.","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"7441_CR37","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.bbrc.2012.10.012","volume":"428","author":"R-f Yang","year":"2012","unstructured":"Yang R-f, Zhao G-w, Liang S-t, et al. Mitofilin regulates cytochrome c release during apoptosis by controlling mitochondrial cristae remodeling. Biochem Biophys Res Commun. 2012;428(1):93\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"7441_CR38","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/nrm2434","volume":"9","author":"YP Ow","year":"2008","unstructured":"Ow YP, Green DR, Hao Z, Mak TW. Cytochrome c: functions beyond respiration. Nat Rev Mol Cell Biol. 2008;9(7):532\u201342.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"7441_CR39","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.freeradbiomed.2021.05.013","volume":"171","author":"D Weissman","year":"2021","unstructured":"Weissman D, Maack C. Redox signaling in heart failure and therapeutic implications. Free Radic Biol Med. 2021;171:345\u201364.","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"7441_CR40","doi-asserted-by":"publisher","first-page":"602","DOI":"10.3390\/biomedicines10030602","volume":"10","author":"A Mongirdien\u0117","year":"2022","unstructured":"Mongirdien\u0117 A, Skrodenis L, Varoneckait\u0117 L, Mierkyt\u0117 G, Gerulis J. Reactive oxygen species induced pathways in heart failure pathogenesis and potential therapeutic strategies. Biomedicines. 2022;10(3):602.","journal-title":"Biomedicines."},{"issue":"2","key":"7441_CR41","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1096\/fj.201801417R","volume":"33","author":"HA Kalpage","year":"2019","unstructured":"Kalpage HA, Bazylianska V, Recanati MA, et al. Tissue-specific regulation of cytochrome c by post-translational modifications: respiration, the mitochondrial membrane potential, ROS, and apoptosis. FASEB J. 2019;33(2):1540\u201353.","journal-title":"FASEB J"},{"key":"7441_CR42","doi-asserted-by":"publisher","first-page":"101947","DOI":"10.1016\/j.redox.2021.101947","volume":"41","author":"MW Park","year":"2021","unstructured":"Park MW, Cha HW, Kim J, et al. NOX4 promotes ferroptosis of astrocytes by oxidative stress-induced lipid peroxidation via the impairment of mitochondrial metabolism in Alzheimer's diseases. Redox Biol. 2021;41:101947.","journal-title":"Redox Biol"},{"key":"7441_CR43","doi-asserted-by":"publisher","first-page":"5080843","DOI":"10.1155\/2019\/5080843","volume":"2019","author":"LJ Su","year":"2019","unstructured":"Su LJ, Zhang JH, Gomez H, et al. Reactive oxygen species-induced lipid peroxidation in apoptosis, autophagy, and ferroptosis. Oxidative Med Cell Longev. 2019;2019:5080843.","journal-title":"Oxidative Med Cell Longev"},{"issue":"7784","key":"7441_CR44","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","volume":"575","author":"K Bersuker","year":"2019","unstructured":"Bersuker K, Hendricks JM, Li Z, et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature. 2019;575(7784):688\u201392.","journal-title":"Nature"},{"issue":"7","key":"7441_CR45","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.7150\/thno.54113","volume":"11","author":"X Wu","year":"2021","unstructured":"Wu X, Li Y, Zhang S, Zhou X. Ferroptosis as a novel therapeutic target for cardiovascular disease. Theranostics. 2021;11(7):3052\u20139.","journal-title":"Theranostics"},{"key":"7441_CR46","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.bbrc.2021.07.090","volume":"572","author":"H Kitakata","year":"2021","unstructured":"Kitakata H, Endo J, Hashimoto S, et al. Imeglimin prevents heart failure with preserved ejection fraction by recovering the impaired unfolded protein response in mice subjected to cardiometabolic stress. Biochem Biophys Res Commun. 2021;572:185\u201390.","journal-title":"Biochem Biophys Res Commun"},{"issue":"18","key":"7441_CR47","doi-asserted-by":"publisher","first-page":"2842","DOI":"10.3390\/cells11182842","volume":"11","author":"Q Li","year":"2022","unstructured":"Li Q, Zhao Z, Zhou X, et al. Ferroptosis: The Potential Target in Heart Failure with Preserved Ejection Fraction. Cells. 2022;11(18):2842.","journal-title":"Cells."},{"issue":"11","key":"7441_CR48","doi-asserted-by":"publisher","first-page":"H1605","DOI":"10.1152\/ajpheart.00423.2014","volume":"307","author":"K Wilson","year":"2014","unstructured":"Wilson K, Guggilam A, West TA, et al. Effects of a myofilament calcium sensitizer on left ventricular systolic and diastolic function in rats with volume overload heart failure. Am J Physiol Heart Circ Physiol. 2014;307(11):H1605\u201317.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"7441_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1254\/jphs.CP0060010","volume":"104","author":"O Yildiz","year":"2007","unstructured":"Yildiz O. Vasodilating mechanisms of levosimendan: involvement of K+ channels. J Pharmacol Sci. 2007;104(1):1\u20135.","journal-title":"J Pharmacol Sci"},{"issue":"6","key":"7441_CR50","doi-asserted-by":"publisher","first-page":"4454","DOI":"10.1002\/ehf2.13669","volume":"8","author":"D Burkhoff","year":"2021","unstructured":"Burkhoff D, Rich S, Pollesello P, Papp Z. Levosimendan-induced venodilation is mediated by opening of potassium channels. ESC Heart Fail. 2021;8(6):4454\u201364.","journal-title":"ESC Heart Fail"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-023-07441-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-023-07441-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-023-07441-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T23:34:50Z","timestamp":1721777690000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-023-07441-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,7]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["7441"],"URL":"https:\/\/doi.org\/10.1007\/s10557-023-07441-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2011741\/v1","asserted-by":"object"}]},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,7]]},"assertion":[{"value":"13 February 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors agree to this definitive version of the article and take responsibility for the veracity of the work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study did not involve human subjects. All the animal experiments were conducted in compliance with the National Research Council\u2019s Guide for the Care and Use of Laboratory Animals. The Animal Care and Use Committee of Fuwai Hospital, Peking Union Medical College of Medicine approved our experiments to ensure humanitarian care for animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}